Pharmacokinetics and Safety of a Novel Extended‐Release Microsphere Formulation of Risperidone in Patients with Schizophrenia or Schizoaffective Disorder
1. 系统已在2025-06-03 14:49:29对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1002/jcph.6143
文献链接: https://accp1.onlinelibrary.wiley.com/doi/10.1002/jcph.6143
其他信息:
出版社: Wiley
作者: David P. Walling; Ying Dong; Robert Litman; Wenyan Wang; Chunli Liu; Joe Tai; Pinglan Liu; Yanan Shi; Wanhui Liu; Fenghua Fu; Kaoxiang Sun